researchers began giving mice lonafarnib 10 weeks intermittent day day schedule evaluated 20 weeks treatment markedly reduced abnormal behaviors seen untreated mice continuously running circles lack normal nest building behavior dramatic effects kosik says control animals 20 weeks sick treated mice not reduced tau abnormalities tangle formation brain atrophy inflammation amazed minimal deposition tau tangles kosik says reduction not elimination brain inflammation known microgliosis drug appears work fundamentally different way previous approaches activating cellular waste clearance systems break toxic proteins previous strategies included reducing tau production blocking aggregation switching tau gene expression efforts met mixed success new findings imply cells